// App-Quantinova.ai

4976 : Combining measures of immune infiltration uncovers predictors of survival in high-grade serous ovarian cancer

Researchers

Presenter

  • Anne Montfort

Principal Investigators

  • Steph J. Owen

  • Anna M. Piskorz

  • Anna Supernat

  • Luiza Moore

  • Sarwah Al-Khalidi

  • Steffen Boehm

  • Paul Pharoah

  • Jacqueline McDermott

  • Frances R. Balkwill

  • James D. Brenton

Medical Centers

  • Bart's Cancer Institute, London, United Kingdom

  • Cancer Research UK, Cambridge, United Kingdom.

  • University College London Hospitals NHS Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • High grade serous ovarian cancer

Biomarkers

  • Breast cancer type 1 susceptibility protein

  • Breast cancer type 2 susceptibility protein

  • Phosphatase and tensin homolog

  • Cluster of differentiation 8A

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved